# A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

Study · id `cardio:ct-nct07474649` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07474649](<https://clinicaltrials.gov/study/NCT07474649>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07474649

Browse, organ or system: Heart; Metabolism  
Browse, condition area: Risk and prevention; Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 103 participants.

## Technical summary

Registry record NCT07474649. Allocation not applicable; no masking; primary purpose treatment. Start 2026-09-14 (actual); primary completion 2028-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 103 participants (planned count; ClinicalTrials.gov record NCT07474649, source copy `cardio:ctgov-nct07474649-2026-11-17`, retrieved 2026-11-18)
- Started: 2026-09-14 (actual) (ClinicalTrials.gov record NCT07474649, source copy `cardio:ctgov-nct07474649-2026-11-17`, retrieved 2026-11-18)
- Primary completion: 2028-06-01 (anticipated) (ClinicalTrials.gov record NCT07474649, source copy `cardio:ctgov-nct07474649-2026-11-17`, retrieved 2026-11-18)
- Completion: 2028-10-02 (anticipated) (ClinicalTrials.gov record NCT07474649, source copy `cardio:ctgov-nct07474649-2026-11-17`, retrieved 2026-11-18)
- Countries: Germany; Italy; Spain (ClinicalTrials.gov record NCT07474649, source copy `cardio:ctgov-nct07474649-2026-11-17`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07474649-2026-11-17`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events
- Condition: Coronary Atherosclerosis
- Condition: Mixed Dyslipidemia
- Condition: Hypercholesterolemia
- Intervention (Drug): Bempedoic acid
- Intervention (Drug): Ezetimibe
- Intervention (Drug): Rosuvastatin
- Intervention (Drug): Atorvastatin
- Lead sponsor: Daiichi Sankyo
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry intervention name matches this record: Bempedoic acid (`cardio:bempedoic-acid`)
- Registry intervention name matches this record: Ezetimibe (`cardio:ezetimibe`)
- Registry intervention name matches this record: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry lists this organization as the lead sponsor: Daiichi Sankyo (`cardio:org-daiichi-sankyo`)

## Provenance

Content hash: feab97290471b4c7d0d38f52e2effb6e198c70da30bfa7dc9d328248a9906542
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
